The weanling male rat as an assay for endocrine disruption: Preliminary observations

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 3, 1997, Pages 330-337

  Ashby, J ^a   Lefevre, P A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTIANDROGEN; CYPROTERONE ACETATE; VINCLOZOLIN;

ACCESSORY SEX ORGAN; ANIMAL MODEL; ARTICLE; BODY WEIGHT; ENDOCRINOLOGY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEMINAL VESICLE; WEANING;

ANIMALIA; ARACHIS;

EID: 0031457471     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1177     Document Type: Article

References (15)

1. Ashby J. The efficient preparation of corn oil suspensions. Mutat. Res. 187:1987;45.
2. Anderson S. A., Fall P. A., Pierce S. W., Tyl R. W., Gray L. E. Testicular and adrenal response in adult male Long-Evans rats after antiandrogen vinclozolin (vin) exposure. J. Androl. Suppl. 43:1995.
3. Fail P. A., Pearce S. W., Anderson S. A., Tyl R. W., Gray L. E. Endocrine and reproductive toxicity of vinclozoline(in) in male Long-Evans hooded rats. Fundam. Appl. Pharmacol. 15:1995;293.
4. Gray L. E., Ostby J. S., Kelce W. R. Developmental effects of an environmental antiandrogen: The fungicide vinclozolin alters sex differentiation of the male rat. Toxicol. Appl. Pharmacol. 129:1994;46-52.
5. Imperato-McGinley J., Sanchez R. S., Spenser J. R., Yee B., Vaughan E. D. Comparison of the effects of the 5α-reductase inhibitor finesteride and the antiandrogen flutamide on prostate and genital differentiation: Dose response studies. Endocrinology. 131:1992;1149-1156.
6. Kelce W. R., Wilson E. M. Environmental antiandogens: Developmental effects, molecular mechanisms, and clinical implications. J. Mol. Med. 75:1997;198-207.
7. Kelce W. R., Monosson E., Gamcsik M. P., Laws S. C., Gray L. E. Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol. Appl. Pharmacol. 126:1994;276-285.
8. Nagel S. C., vomSaal F. S., Thayer K. A., Dhar M. G., Boechler M., Welshons W. V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relativein vivo. Environ. Health Perspect. 105:1997;70-76.
9. Odum J., Lefevre P. A., Tittensor S., Paton D., Harris C. A., Beresford N. A., Sumpter J. P., Ashby J. The rodent uterotrophic assay: Critical protocol feature studies with nonylphenols, comparison with a yeast oestrogenicity assay. Regul. Toxicol. Pharmacol. 25:1997;176-188.
10. Reel J. R., Lamb J. C., Neal B. H. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam. Appl. Toxicol. 34:1996;288-305.
11. Sharpe R. M., Fisher J. S., Millar M. M., Jobling S., Sumpter J. P. Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 103:1995;1136-1143.
12. Shelby M. D., Newbould R. R., Tully D. B., Chae K., Davis V. L. Assessing environmental chemicals for estrogenicity using a combination ofin vitroin vivo. Environ. Health Perspect. 104:1996;1296-1300.
13. K. J. Turner, M. Millar, J. Fisher, R. M. Sharpe, 1997, Evaluation of the role of oestrogens in sperm production and fertility in the adult rat.
14. B. Van Ravenzwaay, 1992, Discussion of prenatal and reproductive toxicity data of Reg. No. 83-258 (vinclozolin).
15. Walsh P. C., Gittes R. F., Ruben F. Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens. Endocrinology. 87:1970;624-628.